The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125239721 12523972 1 I 2015 20151221 20160704 20160704 PER US-JAZZ-2015-US-022275 JAZZ 0.00 F Y 0.00000 20160704 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125239721 12523972 1 PS XYREM SODIUM OXYBATE 1 Oral 2.25 G, BID U 21196 2.25 G ORAL SOLUTION
125239721 12523972 2 SS XYREM SODIUM OXYBATE 1 Oral DOSE ADJUSTMENTS U 21196 ORAL SOLUTION
125239721 12523972 3 SS XYREM SODIUM OXYBATE 1 Oral 3 G, BID U 21196 3 G ORAL SOLUTION
125239721 12523972 4 SS CONCERTA METHYLPHENIDATE HYDROCHLORIDE 1 54 MG, QD 0 54 MG
125239721 12523972 5 C DIAZEPAM. DIAZEPAM 1 U 0 TABLET
125239721 12523972 6 C PROZAC FLUOXETINE HYDROCHLORIDE 1 UNK U 0
125239721 12523972 7 C PROZAC FLUOXETINE HYDROCHLORIDE 1 3 TABLETS DAILY U 0
125239721 12523972 8 C XANAX ALPRAZOLAM 1 UNK U 0 TABLET
125239721 12523972 9 C HYDROCODONE BITARTRATE AND ACETAMINOPHEN ACETAMINOPHENHYDROCODONE BITARTRATE 1 UNK U 0
125239721 12523972 10 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 UNK U 0 CAPSULE
125239721 12523972 11 C Biotin BIOTIN 1 UNK U 0 POWDER
125239721 12523972 12 C INDOMETHACIN. INDOMETHACIN 1 Oral 75 MG, BID U 0 75 MG CAPSULE
125239721 12523972 13 C LO LOESTRIN FE ETHINYL ESTRADIOLNORETHINDRONE ACETATE 1 UNK U 0 TABLET
125239721 12523972 14 C TOPAMAX TOPIRAMATE 1 UNK U 0 TABLET
125239721 12523972 15 C TOPAMAX TOPIRAMATE 1 UNK U 0 TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125239721 12523972 1 Narcolepsy
125239721 12523972 4 Product used for unknown indication
125239721 12523972 5 Product used for unknown indication
125239721 12523972 6 Product used for unknown indication
125239721 12523972 7 Product used for unknown indication
125239721 12523972 8 Product used for unknown indication
125239721 12523972 9 Product used for unknown indication
125239721 12523972 10 Product used for unknown indication
125239721 12523972 11 Product used for unknown indication
125239721 12523972 12 Product used for unknown indication
125239721 12523972 13 Product used for unknown indication
125239721 12523972 14 Product used for unknown indication
125239721 12523972 15 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125239721 12523972 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125239721 12523972 Anxiety
125239721 12523972 Decreased appetite
125239721 12523972 Drug ineffective
125239721 12523972 Hyperhidrosis
125239721 12523972 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125239721 12523972 1 201503 2015 0
125239721 12523972 3 201507 0
125239721 12523972 6 20150423 0
125239721 12523972 7 20150325 20150506 0
125239721 12523972 8 20150313 0
125239721 12523972 9 20150309 0
125239721 12523972 10 20150309 0
125239721 12523972 11 20150302 0
125239721 12523972 12 20150302 0
125239721 12523972 13 20150302 0
125239721 12523972 14 20150302 0
125239721 12523972 15 20150302 0